Related Experiment Video
Updated: Aug 3, 2026

16:19
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
Liver transplantation. Initial experience in the Veterans Administration
R I Leventhal1, D H Berman, S Lasky
1Division of Gastroenterology, University of Pittsburgh, School of Medicine, Pennsylvania 15261.
Digestive Diseases and Sciences
|June 1, 1990
Summary
The Veterans Administration
Area of Science:
- Transplantation Medicine
- Hepatology
- Surgical Outcomes
Background:
- The Veterans Administration (VA) initiated a liver transplantation program in 1983.
- The program operated until July 1988, serving as the sole authorized center for VA liver transplants.
- This study analyzes the early outcomes and challenges of the VA's liver transplant initiative.
Purpose of the Study:
- To evaluate the process of patient selection and transplantation within the VA system.
- To identify reasons for transplant denial and retransplantation.
- To assess the early survival rates and graft outcomes.
Main Methods:
- Retrospective review of patient data from 146 VA Medical Centers.
- Analysis of 101 patient evaluations and 67 liver transplantations (OLTx).
- Examination of reasons for transplant denial and retransplantation, including graft survival rates.
Main Results:
- 69% of initial contacts led to patient evaluation, with 76% accepted for OLTx.
- Common reasons for denial included metastatic cancer, alcoholism, and concurrent medical issues.
- The annual number of transplants increased from 1 to 21; retransplantation rate was 22% with 46% survival for second grafts.
- Reasons for retransplantation included rejection, hepatic artery thrombosis, and graft failure.
Conclusions:
- The VA liver transplant program demonstrated an increasing capacity for procedures during its operational period.
- Patient selection criteria and post-transplant complications, such as rejection and thrombosis, presented significant challenges.
- While early survival rates showed promise, retransplantation outcomes highlighted areas for improvement.

